Dose-Sparing Mpox Vaccine Provides Similar Antibody Response To Standard Regimen, Study Finds

Infectious Disease Advisor (5/20, Nye) reports, “Antibody responses induced by a dose-sparing mpox vaccine and the standard regimen were found to be equivalent at 6 weeks following receipt of the second vaccine dose, according to a press release from the National Institutes of Health (NIH).” The dose-sparing mpox vaccine, which used “one-fifth the standard MVA-BN dose,” showed “equivalent antibody levels to those who received the standard dose.”